| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |